Caseware UK (AP4) 2023.0.135 2023.0.135 2023-08-312023-08-31614No description of principal activity1truetrue2022-09-01false1The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 10542613 2022-09-01 2023-08-31 10542613 2021-09-01 2022-08-31 10542613 2023-08-31 10542613 2022-08-31 10542613 c:Director1 2022-09-01 2023-08-31 10542613 d:Buildings d:ShortLeaseholdAssets 2022-09-01 2023-08-31 10542613 d:Buildings d:ShortLeaseholdAssets 2023-08-31 10542613 d:Buildings d:ShortLeaseholdAssets 2022-08-31 10542613 d:PlantMachinery 2022-09-01 2023-08-31 10542613 d:PlantMachinery 2023-08-31 10542613 d:PlantMachinery 2022-08-31 10542613 d:PlantMachinery d:OwnedOrFreeholdAssets 2022-09-01 2023-08-31 10542613 d:PlantMachinery d:LeasedAssetsHeldAsLessee 2022-09-01 2023-08-31 10542613 d:OfficeEquipment 2022-09-01 2023-08-31 10542613 d:OfficeEquipment 2023-08-31 10542613 d:OfficeEquipment 2022-08-31 10542613 d:OfficeEquipment d:OwnedOrFreeholdAssets 2022-09-01 2023-08-31 10542613 d:OfficeEquipment d:LeasedAssetsHeldAsLessee 2022-09-01 2023-08-31 10542613 d:OwnedOrFreeholdAssets 2022-09-01 2023-08-31 10542613 d:LeasedAssetsHeldAsLessee 2022-09-01 2023-08-31 10542613 d:CurrentFinancialInstruments 2023-08-31 10542613 d:CurrentFinancialInstruments 2022-08-31 10542613 d:Non-currentFinancialInstruments 2023-08-31 10542613 d:Non-currentFinancialInstruments 2022-08-31 10542613 d:CurrentFinancialInstruments d:WithinOneYear 2023-08-31 10542613 d:CurrentFinancialInstruments d:WithinOneYear 2022-08-31 10542613 d:Non-currentFinancialInstruments d:AfterOneYear 2023-08-31 10542613 d:Non-currentFinancialInstruments d:AfterOneYear 2022-08-31 10542613 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2023-08-31 10542613 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2022-08-31 10542613 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2023-08-31 10542613 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2022-08-31 10542613 d:ShareCapital 2023-08-31 10542613 d:ShareCapital 2022-08-31 10542613 d:RetainedEarningsAccumulatedLosses 2023-08-31 10542613 d:RetainedEarningsAccumulatedLosses 2022-08-31 10542613 c:FRS102 2022-09-01 2023-08-31 10542613 c:AuditExempt-NoAccountantsReport 2022-09-01 2023-08-31 10542613 c:FullAccounts 2022-09-01 2023-08-31 10542613 c:PrivateLimitedCompanyLtd 2022-09-01 2023-08-31 10542613 d:HirePurchaseContracts d:WithinOneYear 2023-08-31 10542613 d:HirePurchaseContracts d:WithinOneYear 2022-08-31 10542613 d:HirePurchaseContracts d:BetweenOneFiveYears 2023-08-31 10542613 d:HirePurchaseContracts d:BetweenOneFiveYears 2022-08-31 10542613 d:AcceleratedTaxDepreciationDeferredTax 2023-08-31 10542613 d:AcceleratedTaxDepreciationDeferredTax 2022-08-31 10542613 d:TaxLossesCarry-forwardsDeferredTax 2023-08-31 10542613 d:TaxLossesCarry-forwardsDeferredTax 2022-08-31 10542613 d:PlantMachinery d:LeasedAssetsHeldAsLessee 2023-08-31 10542613 d:PlantMachinery d:LeasedAssetsHeldAsLessee 2022-08-31 10542613 e:PoundSterling 2022-09-01 2023-08-31 iso4217:GBP xbrli:pure

Registered number: 10542613










PRIMA AESTHETICS UK LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 AUGUST 2023

 
PRIMA AESTHETICS UK LIMITED
REGISTERED NUMBER: 10542613

STATEMENT OF FINANCIAL POSITION
AS AT 31 AUGUST 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 4 
90,072
71,819

Current assets
  

Stocks
  
13,000
10,000

Debtors: amounts falling due within one year
 5 
14,966
5,544

Cash at bank and in hand
  
15,078
7,827

  
43,044
23,371

Creditors: amounts falling due within one year
 6 
(74,933)
(30,243)

Net current liabilities
  
 
 
(31,889)
 
 
(6,872)

Total assets less current liabilities
  
58,183
64,947

Creditors: amounts falling due after more than one year
 7 
(53,484)
(49,937)

Provisions for liabilities
  

Deferred tax
 10 
(4,570)
(2,971)

Net assets
  
129
12,039


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
29
11,939

  
129
12,039


Page 1

 
PRIMA AESTHETICS UK LIMITED
REGISTERED NUMBER: 10542613
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 AUGUST 2023

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 






G Estebanez
Director

Date: 29 September 2024

The notes on pages 3 to 11 form part of these financial statements.

Page 2

 
PRIMA AESTHETICS UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

1.


General information

Prima Aesthetics UK Limited (10542613) is a private company limited by shares. It is incorporated in England & Wales. The registered office is 113 Lache Lane, Chester, CH4 7LT.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 3

 
PRIMA AESTHETICS UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

2.Accounting policies (continued)


2.3
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Improvements to leasehold
-
10%
on cost
Plant and machinery
-
20%
on cost
Office equipment
-
25%
on cost

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.5

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

Page 4

 
PRIMA AESTHETICS UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

2.Accounting policies (continued)

 
2.6

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.7

Debtors

Short term debtors are measured at transaction price, less any impairment.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Page 5

 
PRIMA AESTHETICS UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

2.Accounting policies (continued)

 
2.9

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

 
2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 6

 
PRIMA AESTHETICS UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

2.Accounting policies (continued)

 
2.11

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.12

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.13

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2022 - 1).

Page 7

 
PRIMA AESTHETICS UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

4.


Tangible fixed assets





Improvement to leasehold
Plant and machinery
Office equipment
Total

£
£
£
£



Cost or valuation


At 1 September 2022
3,460
58,560
20,001
82,021


Additions
4,973
21,500
13,751
40,224



At 31 August 2023

8,433
80,060
33,752
122,245



Depreciation


At 1 September 2022
202
976
9,024
10,202


Charge for the year on owned assets
614
-
5,703
6,317


Charge for the year on financed assets
-
15,654
-
15,654



At 31 August 2023

816
16,630
14,727
32,173



Net book value



At 31 August 2023
7,617
63,430
19,025
90,072



At 31 August 2022
3,258
57,584
10,977
71,819

The net book value of assets held under finance leases or hire purchase contracts, included above, are as follows:


2023
2022
£
£



Plant and machinery
63,430
57,584

Page 8

 
PRIMA AESTHETICS UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

5.


Debtors

2023
2022
£
£


Other debtors
14,664
2,202

Prepayments and accrued income
302
3,342

14,966
5,544



6.


Creditors: Amounts falling due within one year

2023
2022
£
£

Bank loans
2,495
2,431

Trade creditors
8,034
-

Other taxation and social security
42,619
7,617

Obligations under finance lease and hire purchase contracts
12,416
7,201

Other creditors
-
6,769

Accruals and deferred income
9,369
6,225

74,933
30,243



7.


Creditors: Amounts falling due after more than one year

2023
2022
£
£

Bank loans
5,401
7,897

Net obligations under finance leases and hire purchase contracts
48,083
42,040

53,484
49,937


Page 9

 
PRIMA AESTHETICS UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

8.


Loans


Analysis of the maturity of loans is given below:


2023
2022
£
£

Amounts falling due within one year

Bank loans
2,495
2,431

Amounts falling due 1-2 years

Bank loans
2,558
2,495

Amounts falling due 2-5 years

Bank loans
2,844
5,402


7,897
10,328



9.


Hire purchase and finance leases


Minimum lease payments under hire purchase fall due as follows:

2023
2022
£
£


Within one year
12,416
7,201

Between 1-5 years
48,083
42,040

60,499
49,241


10.


Deferred taxation




2023


£






At beginning of year
(2,971)


Charged to profit or loss
(1,599)



At end of year
(4,570)

Page 10

 
PRIMA AESTHETICS UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023
 
10.Deferred taxation (continued)

The provision for deferred taxation is made up as follows:

2023
2022
£
£


Accelerated capital allowances
(20,614)
(17,140)

Tax losses carried forward
16,044
14,169

(4,570)
(2,971)

Page 11